Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP961045.RArnL2SZU_IBVMZjvVnGmucSn2Qc-w9KYlXElZmIP2oZg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP961045.RArnL2SZU_IBVMZjvVnGmucSn2Qc-w9KYlXElZmIP2oZg130_assertion type Assertion NP961045.RArnL2SZU_IBVMZjvVnGmucSn2Qc-w9KYlXElZmIP2oZg130_head.
- NP961045.RArnL2SZU_IBVMZjvVnGmucSn2Qc-w9KYlXElZmIP2oZg130_assertion description "[Our analysis also identified 10,775 differentially methylated (DM) loci (17% out of 62,692 loci) located in or surrounding the gene promoters, 4% of which reside in known Differentially Methylated Regions (DMRs) including reprogramming specific DMRs and cancer specific DMRs, while the rest (10,315) involving 4,106 genes could be potential new HCC DMR loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP961045.RArnL2SZU_IBVMZjvVnGmucSn2Qc-w9KYlXElZmIP2oZg130_provenance.
- NP961045.RArnL2SZU_IBVMZjvVnGmucSn2Qc-w9KYlXElZmIP2oZg130_assertion evidence source_evidence_literature NP961045.RArnL2SZU_IBVMZjvVnGmucSn2Qc-w9KYlXElZmIP2oZg130_provenance.
- NP961045.RArnL2SZU_IBVMZjvVnGmucSn2Qc-w9KYlXElZmIP2oZg130_assertion SIO_000772 23437062 NP961045.RArnL2SZU_IBVMZjvVnGmucSn2Qc-w9KYlXElZmIP2oZg130_provenance.
- NP961045.RArnL2SZU_IBVMZjvVnGmucSn2Qc-w9KYlXElZmIP2oZg130_assertion wasDerivedFrom befree-20150227 NP961045.RArnL2SZU_IBVMZjvVnGmucSn2Qc-w9KYlXElZmIP2oZg130_provenance.
- NP961045.RArnL2SZU_IBVMZjvVnGmucSn2Qc-w9KYlXElZmIP2oZg130_assertion wasGeneratedBy ECO_0000203 NP961045.RArnL2SZU_IBVMZjvVnGmucSn2Qc-w9KYlXElZmIP2oZg130_provenance.